December 13th 2022
September 9th 2021
Catherine Callaghan Coombs, MD, discusses the efficacy results of the ongoing phase 1/2 BRUIN study with pirtobrutinib in chronic lymphocytic leukemia.
February 8th 2021
January 8th 2021